Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer's disease: A non-invasive approach.
Administration, Intranasal
Alzheimer Disease
/ drug therapy
Animals
Antioxidants
/ administration & dosage
Biopolymers
/ chemistry
Cations
Cell Line
Chitosan
/ chemistry
Delayed-Action Preparations
Dogs
Drug Carriers
/ chemistry
Humans
Lutein
/ administration & dosage
Male
Mice
Nanoparticles
Oxidative Stress
/ drug effects
Polylactic Acid-Polyglycolic Acid Copolymer
/ chemistry
Rats
Rats, Sprague-Dawley
Tissue Distribution
Antioxidant activity
Cell internalization mechanism
Core/Shell Nanoparticles
Intranasal delivery
Lutein
Photo and thermal stability
Journal
International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127
Informations de publication
Date de publication:
30 Aug 2020
30 Aug 2020
Historique:
received:
27
04
2020
revised:
12
06
2020
accepted:
13
06
2020
pubmed:
21
6
2020
medline:
6
3
2021
entrez:
21
6
2020
Statut:
ppublish
Résumé
Present investigation explores cationic biopolymer core/shell nanoparticles (Chitosan@PLGA C/SNPs) for delivering carotenoids to brain via intranasal route for supressing oxidative stress in Alzheimer's disease (AD). The prepared C/SNPs exhibited particle size less than 150 nm with more than 80% of entrapment efficiency. Surface morphology confirmed uniform coating of shell (chitosan) over core PLGA NPs and suggested spherical nature and homogenous dispersion of C/SNPs. In-vitro release study demonstrated sustained release of lutein while C/SNPs permeation enhancement was confirmed by ex-vivo diffusion study. The study also investigated effect of cationic-shell with respect to anionic-core NPs on biocompatibility, cellular uptake, uptake mechanism, reactive-oxygen species (ROS) generation, ROS scavenging activity, blood-brain-barrier (BBB) permeation. The cellular uptake revealed enhanced internalization of nanoparticles via caveolae-mediated endocytosis. In-vitro co-culture model of BBB demonstrated efficient passage for C/SNPs through BBB. Antioxidant assay demonstrated significant ROS scavenging activity of C/SNPs. In-vivo pharmacokinetic and bio-distribution was performed along with in-vivo toxicity and stability. In-vivo toxicity demonstrated absence of any significant toxicity. Photo and thermal stability confirmed protection of lutein by C/SNPs. C/SNPs were highly deposited in brain following intranasal route. The obtained results demonstrate the potential application of cationic C/SNPs for attenuating oxidative stress in brain for effective AD therapy.
Identifiants
pubmed: 32561306
pii: S0378-5173(20)30537-8
doi: 10.1016/j.ijpharm.2020.119553
pii:
doi:
Substances chimiques
Antioxidants
0
Biopolymers
0
Cations
0
Delayed-Action Preparations
0
Drug Carriers
0
Polylactic Acid-Polyglycolic Acid Copolymer
1SIA8062RS
Chitosan
9012-76-4
Lutein
X72A60C9MT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
119553Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.